Cargando…
The global spectrum of protein-coding pharmacogenomic diversity
Differences in response to medications have a strong genetic component. By leveraging publically available data, the spectrum of such genomic variation can be investigated extensively. Pharmacogenomic variation was extracted from the 1000 Genomes Project Phase 3 data (2504 individuals, 26 global pop...
Autores principales: | Wright, G E B, Carleton, B, Hayden, M R, Ross, C J D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817389/ https://www.ncbi.nlm.nih.gov/pubmed/27779249 http://dx.doi.org/10.1038/tpj.2016.77 |
Ejemplares similares
-
Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
por: Wright, Galen E.B., et al.
Publicado: (2018) -
Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics
por: Chan, Sze Ling, et al.
Publicado: (2016) -
The emerging era of pharmacogenomics: current successes, future potential, and challenges
por: Lee, JW, et al.
Publicado: (2014) -
Use of pharmacogenomics in pediatric renal transplant recipients
por: Medeiros, Mara, et al.
Publicado: (2015) -
Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)